Cite
Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance.
MLA
Yu, Jiaqi, et al. “Codelivery of Adriamycin and P-Gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance.” Journal of Pharmaceutical Sciences, vol. 108, no. 5, May 2019, pp. 1788–99. EBSCOhost, https://doi.org/10.1016/j.xphs.2018.12.016.
APA
Yu, J., Chen, H., Jiang, L., Wang, J., Dai, J., & Wang, J. (2019). Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance. Journal of Pharmaceutical Sciences, 108(5), 1788–1799. https://doi.org/10.1016/j.xphs.2018.12.016
Chicago
Yu, Jiaqi, Hao Chen, Linxia Jiang, Jianhong Wang, Jundong Dai, and Jie Wang. 2019. “Codelivery of Adriamycin and P-Gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance.” Journal of Pharmaceutical Sciences 108 (5): 1788–99. doi:10.1016/j.xphs.2018.12.016.